ScholarIQanswers from OpenAlex & ORCID
Philip Kuriakose
ResearcherPublications, citations & collaboration network
Philip Kuriakose is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Philip Kuriakose have?
ScholarIQindexed works
Philip Kuriakose has 176 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Philip Kuriakose have?
ScholarIQcitation count
Philip Kuriakose has 1,377 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Philip Kuriakose?
ScholarIQh-index
Philip Kuriakose has an h-index of 18 in OpenAlex.
What is the i10-index of Philip Kuriakose?
ScholarIQi10-index
Philip Kuriakose has an i10-index of 32 in OpenAlex.
What is the ORCID of Philip Kuriakose?
ScholarIQorcid
The ORCID for Philip Kuriakose is on the source record.
What is the OpenAlex record for Philip Kuriakose?
ScholarIQopenalex
The OpenAlex for Philip Kuriakose is on the source record.
What are the most-cited papers on Philip Kuriakose?
ScholarIQmost cited works
High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
Susan O’Brien, Gary J. Schiller, John Lister, Lloyd E. Damon, Stuart L. Goldberg, Walter E. Aulitzky, Dina Ben‐Yehuda, Wendy Stock, Steven Coutré, Dan Douer, Leonard T. Heffner, Melissa L. Larson, Karen Seiter, Scott E. Smith, Sarit Assouline, Philip Kuriakose, Lori J. Maness, Arnon Nagler, Jacob M. Rowe, Markus Schaich, Ofer Shpilberg, Karen Yee, Guenter Schmieder, Jeffrey A. Silverman, Deborah Thomas, Steven R. Deitcher, Hagop M. Kantarjian
Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes
Guillermo Garcia‐Manero, Guillermo Montalban‐Bravo, Jesús G. Berdeja, Yasmin Abaza, Elias Jabbour, James Essell, Roger M. Lyons, Farhad Ravandi, Michael B. Maris, Brian Heller, Amy E. DeZern, Sunil Babu, David Wright, Bertrand Anz, Ralph V. Boccia, Rami S. Komrokji, Philip Kuriakose, James A. Reeves, Mikkael A. Sekeres, Hagop M. Kantarjian, Richard Ghalie, Gail J. Roboz
Risk of Deep Venous Thrombosis Associated with Chest versus Arm Central Venous Subcutaneous Port Catheters: A 5-Year Single-Institution Retrospective Study
Philip Kuriakose, Gerardo Colón‐Otero, Ricardo Paz‐Fumagalli
A cross-sectional analysis of cardiovascular disease in the hemophilia population
Suman L. Sood, Dunlei Cheng, Margaret V. Ragni, Craig M. Kessler, Doris Quon, Amy D. Shapiro, Nigel S. Key, Marilyn J. Manco‐Johnson, Adam Cuker, Christine L. Kempton, Tzu‐Fei Wang, M. Elaine Eyster, Philip Kuriakose, Annette von Drygalski, Joan Cox Gill, Allison P. Wheeler, Peter A. Kouides, Miguel A. Escobar, Cindy Leissinger, Sarah Galdzicka, Marshall A. Corson, Crystal Watson, Barbara A. Konkle
Pharmacokinetics and safety of OBI‐1, a recombinant B domain‐deleted porcine factor VIII, in subjects with haemophilia A
Christine L. Kempton, Thomas C. Abshire, Ruby Anne E. Deveras, W. Keith Hoots, Joan Cox Gill, Craig M. Kessler, N. S. KEY, Barbara A. Konkle, Philip Kuriakose, Donald E. Macfarlane, Garrett E. Bergman